D-0493-2017 Class II Terminated

Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories) — Rockford, IL

Recall Details

Product Type
Drugs
Report Date
March 15, 2017
Initiation Date
January 27, 2017
Termination Date
March 15, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)

Product Description

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

Reason for Recall

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Distribution Pattern

Nationwide

Code Information

Batch #3083289; Exp. Date 12/2018